Travere Therapeutics, Inc. (TVTX) › Net IncomeTravere Therapeutics, Inc. (TVTX) — Net IncomeAnnual figures by fiscal year, from SEC filings.2011: -$23.0K2012: -$30.34M2013: -$34.62M2014: -$110.94M2015: $117.24M2016: -$47.90M2017: -$59.73M2018: -$102.68M2019: -$146.43M2020: -$169.43M2021: -$180.09M2022: -$278.48M2023: -$111.40M2024: -$321.55M2025: -$25.55M-$25.55M2011Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$25.55M+92.1%2024-$321.55M-188.6%2023-$111.40M+60.0%2022-$278.48M-54.6%2021-$180.09M-6.3%2020-$169.43M-15.7%2019-$146.43M-42.6%2018-$102.68M-71.9%2017-$59.73M-24.7%2016-$47.90M-140.9%2015$117.24M+205.7%2014-$110.94M-220.4%2013-$34.62M-14.1%2012-$30.34M-131703.7%2011-$23.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share